Resiliva@ 80 mg Tablet

Resmetirom is the generic version of Rezdiffra

Used to treat non-cirrhotic NASH, Resiliva helps reduce liver fat and inflammation. Taken once daily, it works by activating thyroid receptor-β in liver cells, improving metabolism and slowing disease progression. Ideal for long-term liver health management.

Resiliva is used in adults for the management of

  • Non-alcoholic steatohepatitis (NASH)

  • Moderate liver fibrosis

  • Advanced liver fibrosis

  • Reduction of hepatic fat

  • Improvement of liver lipid metabolism

  • Support of liver health when combined with diet and exercise

Resiliva is also used as a lower-cost generic alternative to Resmetirom for adults managing NASH with fibrosis.

Learn More

Before taking Resiliva

  • Resiliva is intended for adults diagnosed with NASH

  • Patients must have moderate to advanced liver fibrosis

  • It is not recommended for individuals with cirrhosis

  • Treatment should be combined with diet and exercise

  • Doctors may use non-invasive tools such as FIB-4, elastography, or MRI

  • Patient eligibility follows AASLD guideline-based criteria

  • Only those verified as appropriate candidates should begin therapy

Resiliva should be taken after proper clinical assessment confirming NASH with fibrosis.

How to Take Resiliva

  • Take Resiliva exactly as prescribed by your healthcare provider

  • Typically taken once daily

  • Can be taken with or without food

  • Dosage is based on body weight

  • Follow all dietary and lifestyle recommendations from your provider

Resiliva works best when taken consistently each day according to medical guidance.

Common Side Effects

  • Diarrhea

  • Nausea

  • Itching

  • Stomach pain

  • Vomiting

  • Dizziness

  • Constipation

These side effects are the most commonly reported and should be discussed with your provider if they persist or worsen.